Familial Hypercholestrolemia: New Fixes to Old Family Problems

Wednesday, March 23, 2016 - Thursday, March 23, 2017 12:00 AM   Online, IN

At the conclusion of this activity, participants should be able to:
  1. Recognize the importance of screening patients for familial hypercholesterolemia; and
  2. Specify the new pharmacotherapeutic options for familial hypercholesterolemia, and the future of gene therapy.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Indiana University School of Medicine and Indiana University Health Bloomington Hospital.  The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.